Thieme is a venture capital fund that invests in early-stage companies, focusing on sectors like insurance technology, business intelligence, artificial intelligence, health technology, and pharmaceuticals. They write checks between $500,000 and $10,000,000, with a notable investment in Xund. The parent company, The Thieme Group, employs 950 people and provides medical and chemistry information, software, and services globally. Their offerings include medical education databases, diagnostic software, and chronic disease management programs. They publish journals and books both electronically and in print, with offices in Germany, the U.S., India, and Brazil.
